 David Pendarvis, Chief Administrative Officer at Resmed NYSE:RMD, made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Pendarvis sold 1,487 shares of Resmed at a price of 292.16 per share. 